0001209191-18-045333.txt : 20180803 0001209191-18-045333.hdr.sgml : 20180803 20180803170330 ACCESSION NUMBER: 0001209191-18-045333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Brenton CENTRAL INDEX KEY: 0001596103 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36309 FILM NUMBER: 18992709 MAIL ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inogen Inc CENTRAL INDEX KEY: 0001294133 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 BUSINESS PHONE: 805-562-0500 MAIL ADDRESS: STREET 1: 326 BOLLAY DRIVE CITY: GOLETA STATE: CA ZIP: 93117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001294133 Inogen Inc INGN 0001596103 Taylor Brenton C/O INOGEN, INC. 326 BOLLAY DRIVE GOLETA CA 93117 0 1 0 0 EVP, Engineering Common Stock 2018-08-01 4 A 0 5000 44.19 A 41576 D Common Stock 2018-08-01 4 S 0 600 196.194 D 40976 D Common Stock 2018-08-01 4 S 0 2000 196.923 D 38976 D Common Stock 2018-08-01 4 S 0 1000 198.257 D 37976 D Common Stock 2018-08-01 4 S 0 1200 199.2492 D 36776 D Common Stock 2018-08-01 4 S 0 200 200.473 D 36576 D Common Stock 842 I By Spouse Stock Option (Right to Buy) 44.19 2018-08-01 4 M 0 5000 0.00 D 2023-05-11 Common Stock 5000 42500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $195.95 to $196.48 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $196.60 to $197.46 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 1,000 shares sold in the price range of $197.79 to $198.54 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Represents the weighted average share price of an aggregate total of 1,200 shares sold in the price range of $198.84 to $199.63 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $200.39 to $200.52 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. /s/ Alison Bauerlein, as Attorney-in-Fact 2018-08-03